News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol. More deflections!
Nope. Yours. I live in the reality of building a solid foundation for once-in-a-lifetime, Holy Grail, sustainability. It kinda takes development and innovation into consideration on a daily basis. Keep spinning, though. It's entertaining to see how far some will go in maintaining deflections.
*****FILING A COMPLAINT AGAINST KBLB*****
For those that would like to file a complaint against KBLB:
We strongly encourage the public (whistleblowers and non-whistleblowers) to submit any tips, complaints, and referrals (TCRs) using the SEC's online TCR system and complaint form at https://www.sec.gov/tcr.
https://www.sec.gov/tcr
Here are your facts:
*****UPDATED: KBLB - FAILURE AFTER FAILURE (OR SCAM AFTER SCAM????)*****
NEW: 2024: Metric-ton production one month ahead of schedule - FAILED
NEW: 2024: Metric ton of spider-ish silk produced - FAILED
NEW: 2021-2024: Kings / MtheMovement Committed to Purchase Up to $40 Million in Spidersilk - FAILED
NEW: 2024: Kings / MtheMovement Committed to Purchase Min $12 Million in Spidersilk - FAILED
NEW: 2024: GSS - FAILED
2023: Air Force Contract is a Slam Dunk - FAILED
2023: Kings / MtheMovement to Purchase Up To $12 Million in Spidersilk - FAILED
2023: Commercial production - FAILED
2022: Commercial production - FAILED
2022: Kings / MtheMovement to Purchase Up To $5 Million in Spidersilk - FAILED
2022: Website & apparel launch - FAILED
2021: Kings / MtheMovement to Purchase Up To $3 Million in Spidersilk - FAILED
2021: "The Company ... has now produced enough silk to create a number of different fabric blends." - FAILED
2021: "Spydasilk should hit the ground running" - FAILED
2021: $250K prepayment from Kings / MtheMovement- FAILED
2019-2020: Uplist to NASDAQ - FAILED
2019: Commercial production - FAILED
2019: Appoint Independent Board of Directors - FAILED
2019: Polartec MOU - FAILED
2018: "Our recombinant spider silk silkworm technology is a direct drop-in replacement for traditional silkworms and allows us to move quickly, with minimal investment, to bring new products to market" - FAILED
2018: ““We are busy preparing silkworm eggs for shipment and putting the team in place at Prodigy to hit the ground running.” - FAILED
2016-2018: Army Contract - FAILED
2016: “the Company is on schedule to produce all of the recombinant spider silk necessary to fulfill its contract with the US Government on time” - FAILED
2017: Mulberry facility in Texas - FAILED
2014-2015: "R&D .... is no longer necessary" - FAILED
2014-2015: “Scale and sale” - FAILED
2013-2015: Commercialization of Big Red - FAILED
2013-2014: Warwick Mills Partnership - FAILED
2013: SSM Industries Partnership - FAILED
And those are just a few of the MANY, MANY FAILURES that KBLB has had over the years….
Dream on…. You’re actually starting to believe your delusional lies. When Kim gets this loan it will be for expansion and a sales team.
Keep posting lies…
Yet the pumpers continue to act like the company is a huge success. Stop fooling yourselves. Once dilution comes, the share price is done
You claim the company is a failure, the CEO is a 'scumbag,' and dilution will tank the share price. Yet here you are, obsessively posting about a company you insist has no future. Why? Because it’s one thing to be disappointed or skeptical, but it’s another to play make-believe as an adult, spinning baseless narratives in an attempt to convince other adults delusions are reality.
This constant bitterness doesn’t reflect the company’s actual progress—it reflects faux frustration and an inability to engage with the facts. Playing pretend might work in fairy tales, but in the real world, facts and measurable progress win every time.
The Scumbag CEO said that he was going to make a metric ton last year. Did he do that? The answer is a resounding NO! Did he even get close? Once again, NO!
How much BAM-1 silk have they sold? $0
How much have total liabilities do they have? Over $9 MILLION
How many shares will he have to dilute this year? LOTS
Yet the pumpers continue to act like the company is a huge success. Stop fooling yourselves. Once dilution comes, the share price is done....
<< Things should start picking up really soon. >>
Is "really soon" sooner than "soon"? If so, how soon is "really soon"?
<< most of those stock sales were done when he wasn't filing Form 4's for his sales. >>
That is correct. The Scumbag CEO didn't file the legally-required, SEC forms for over a decade, during which time he sold over 100 MILLION shares (yes, that is correct, 100 MILLION shares).
While you keep painting negativity, reality is where I'll go...
This information paints a picture of Mr. T's exceptional commitment to KBLB and his willingness to defer personal financial gain for the sake of the company’s survival and growth. Let’s break this down into key takeaways:
1. Deferred Salary Demonstrates Sacrifice
From 2011 through 2023, Kim Thompson consistently deferred a significant portion (and sometimes the entirety) of his salary to conserve company resources. His unpaid compensation has accrued to $3.5 million, reflecting years of financial sacrifice.
Instead of demanding immediate payment, Thompson deferred earnings to keep KBLB afloat during cash-constrained periods. His willingness to defer salary at significant personal expense (even as it accrued modest interest) is a testament to his dedication to the company’s vision.
2. Declined Benefits
Thompson also declined life and disability insurance benefits to further conserve company cash, an uncommon move for someone in his position.
This underscores a deep prioritization of company resources over personal perks or entitlements.
3. Financial Support Through Loans
On top of deferring salary, Thompson personally loaned the company millions, accruing additional interest of $2.6 million. This reflects not only financial commitment but confidence in the company’s future success.
CEOs lending significant personal funds to their companies is rare in the corporate world, particularly in a high-risk field like biotechnology.
4. A Long-Term Vision at Personal Expense
By deferring salary and providing loans, Thompson has aligned his financial well-being with the company’s success. He has:
—Forgone immediate earnings to fund the company’s operations.
—Tied the repayment of his compensation and loans to the company’s financial health and eventual profitability.
This is a far cry from the narrative some critics try to spin about him "lining his pockets." His actions show that he has continuously prioritized the company’s survival and development over personal enrichment.
5. Accrued Interest and Payable Balances
Yes, the deferred salaries and loans have accrued interest (as expected), but this is entirely standard in such arrangements. The 3% annual interest rate is modest, especially compared to the potential costs of external financing or dilution.
This setup ensures Thompson is eventually compensated fairly without forcing the company to take on high-interest debt from third-party sources or dilute shareholder equity prematurely.
6. Negative Narratives Fall Flat
Critics who argue that Thompson is overpaid or self-serving ignore these critical facts:
—Thompson’s actual take-home salary over the years has been minimal.
—His deferred compensation and loans demonstrate his skin in the game and confidence in KBLB’s eventual success.
Far from draining company resources, Thompson has preserved them, often at great personal cost.
Conclusion
Mr. T’s actions reflect a CEO who has been all-in for nearly two decades, putting the company’s success ahead of personal enrichment. Critics who harp on his current salary ignore the years of deferred compensation and the substantial financial sacrifices he has made. This long-term alignment with KBLB’s goals should be seen as a strength, not a weakness.
When the company achieves large-scale commercialization, these deferred payments will be a fraction of the value created—a testament to Thompson’s commitment and foresight. Anyone spinning this as greed is either misinformed or intentionally misleading.
<< CEO finally started compensating himself >>
"finally"????
The Scumbag CEO has been compensating himself from day 1. He has LITERALLY stuffed MILLIONS of $s of shareholders hard-earned money into his greedy little pockets.
His compensation for 2023 (the most recent year reported) was $867,081. His compensation for 2022 was $552,402. That is over $1.4M in just two years where the Douchbag did basically nothing for the company.
We will learn how much he stuffed into his pockets for 2024 in the next couple of months....
Wash, rinse, repeat....
<< after almost two decades of deferring pay >>
That is a bunch of BS.
It's a shell game. While he might "defer" SOME of his salary on the one hand, he charges the company compound interest and makes MILLIONS of $s off of that as well. And in 15+ years, there is still no commercial product.
According to the latest filings, he made over $333K in compound interest alone in the 1st 9 months of 2024 (which comes to about $450K for the entire year).
"As of September 30, 2024, and December 31, 2023, there was $3,013,256 and $2,680,236, respectively, included in accrued interest – related party, which includes interest on accrued salary and accrued expenses owed to the Company’s Chief Executive Officer."
So your narrative boils down to this: you’re outraged that a CEO finally started compensating himself—at a level still well below market standards for biotech—after almost two decades of deferring pay. If that’s the hill you want to die on, be my guest. But all you’re proving is that your arguments are built on ignorance and pettiness.
AI
